The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19

Bibliographic Details
Main Authors:	Balakrishnan Sadasivam, Shubham Atal, Avik Ray, Swati Sharma
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971220306883

Similar Items

Exploring an unsung stigma factor in COVID-19
by: Avik Ray, et al.
Published: (2020-01-01)

Medication concordance in modern medicine – A critical appraisal from an Indian perspective
by: Shubham Atal, et al.
Published: (2019-01-01)

Early onset gestational diabetes mellitus: A case report and importance of early screening
by: Ahmad Najmi, et al.
Published: (2019-01-01)

Adaptations in teaching modalities for medical undergraduates in response to coronavirus disease 2019 at a single teaching institute in India
by: Swati Sharma, et al.
Published: (2020-12-01)

Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
by: Atiya R Faruqui, et al.
Published: (2021-01-01)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
by: Anil Pareek, et al.
Published: (2020-01-01)

Use of handheld infrared thermometers in COVID-19 pandemic for mass screening: Understanding its implications through a case report
by: Ahmad Najmi, et al.
Published: (2020-01-01)

Hydroxychloroquine, COVID-19, and prophylaxis
by: Viroj Wiwanitkit
Published: (2020-01-01)

Chloroquine, hydroxychloroquine and COVID-19
by: Erickson, T. B., et al.
Published: (2020)

Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
by: PLOS Medicine Staff
Published: (2020-10-01)

Role of materiovigilance in COVID era: An update
by: Ahmad Najmi, et al.
Published: (2021-01-01)

The use of Hydroxychloroquine in the Treatment of COVID-19
by: Kamer TECEN-YÜCEL, et al.
Published: (2020-09-01)

Chloroquine and hydroxychloroquine for COVID-19 treatment
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2020-05-01)

Chloroquine and hydroxychloroquine in the context of COVID-19
by: Ashutosh M Shukla, et al.
Published: (2020-04-01)

Hydroxychloroquine and QTc: beyond COVID-19
by: Alberto Castagna, et al.
Published: (2020-10-01)

The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?
by: Nicolas Dauby, et al.
Published: (2021-02-01)

Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19
by: Stephane Picot, et al.
Published: (2020-06-01)

No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19
by: Kenneth Sands, et al.
Published: (2021-03-01)

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
by: Cathrine Axfors, et al.
Published: (2021-05-01)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
by: Nour K. Younis, et al.
Published: (2020-11-01)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
by: Javad Mahmoudi, et al.
Published: (2021-01-01)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01)

Hydroxychloroquine as Prophylaxis for COVID-19: A Review
by: Manuela Monti, et al.
Published: (2020-12-01)

Chloroquine, hydroxychloroquine, and COVID-19, the Libyan prospective
by: Abdalla Salem Elhwuegi
Published: (2020-01-01)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
by: Alter, S., et al.
Published: (2022)

Role of hydroxychloroquine in multidrug treatment of COVID-19
by: Peter A. McCullough, et al.
Published: (2021-09-01)

The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
by: Taylor Morrisette, et al.
Published: (2020-08-01)

Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic
by: Chai, Peter R., et al.
Published: (2020)

Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
by: Faizan Mazhar, et al.
Published: (2020-12-01)

Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
by: Yan Chen, et al.
Published: (2020-07-01)

Increasing accessibility in COVID-19 clinical trials
by: Vijay Shankar Balakrishnan
Published: (2020-05-01)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
by: Rosa Camila Lucchetta, et al.
Published: (2020-04-01)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
by: Filippo Albani, et al.
Published: (2020-08-01)

Hydroxychloroquine-Associated Hypoglycemia in Hemodialysis Patients With COVID-19
by: Ahmet Burak Dirim, et al.
Published: (2020-10-01)

Therapeutic status of hydroxychloroquine in COVID-19: A review
by: Kirandeep Kaur, et al.
Published: (2020-01-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
by: Carlos Enrique Salgado-Fuentes
Published: (2021-05-01)

Ethical Considerations of Hydroxychloroquine During the COVID-19 Pandemic
by: Amy Reese
Published: (2021-08-01)

Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
by: Hany M. Dabbous, et al.
Published: (2021-03-01)

Integrating palliative care with primary care: A synergistic mix
by: Avik Ray, et al.
Published: (2019-01-01)

Ranitidine-induced galactorrhea: Exploring the intricacies
by: Avik Ray, et al.
Published: (2020-01-01)